# The DEtermining Statin Intolerance FOr Rosuvastatin (DESIFOR) Trial

> **NCT03889314** · PHASE4 · UNKNOWN · sponsor: **Minneapolis Heart Institute Foundation** · enrollment: 25 (actual)

## Conditions studied

- Cardiovascular Risk Factor
- Cardiovascular Diseases
- Adverse Effect

## Interventions

- **DRUG:** Rosuvastatin 20mg
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03889314
- **Lead sponsor:** Minneapolis Heart Institute Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-26
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2022-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03889314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03889314, "The DEtermining Statin Intolerance FOr Rosuvastatin (DESIFOR) Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03889314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*